Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
New JAMA study backs RSV vaccine safety during pregnancy Dr. Kamal Kant Kohli10 July 2024 4:00 AM ISTVaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk...
GSK pharma Gets CDSCO Panel Nod To study Respiratory Syncytial Virus vaccine RSVPreF3 OA Dr. Divya Colin10 Jun 2024 6:00 PM ISTNew Delhi: Advising to include clinical trial sites from various states in the southern part of India, the Subject Expert Committee (SEC) functional...
USFDA grants Emergency Use Authorization for Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV Ruchika Sharma10 Jun 2024 3:26 PM ISTBasel: Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)for its cobas liat...
New tool may help identify infants at high risk for poor RSV outcomes, reveals study Dr. Kamal Kant Kohli24 May 2024 7:30 AM ISTOn the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool...
Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent: Lancet Dr. Kamal Kant Kohli3 May 2024 7:00 PM ISTNirsevimab use may reduce infant hospitalizations due to respiratory syncytial virus (RSV) by 82 percent, shows real world evidence published in The...
Contracting RSV Before Age 2 Can Cause Long-term Lung Changes and functional Impairment, finds study Dr. Kamal Kant Kohli25 April 2024 10:00 AM ISTInfants and children who have severe cases of respiratory syncytial virus (RSV) before age 2 are likely to have changes to their lung structure and...
Respiratory syncytial virus has increased frequency of transplacental transmission in Pregnant Women: Study Jacinthlyn Sylvia12 April 2024 9:00 AM ISTA recent comprehensive study illuminated the transmission of respiratory viral infections from pregnant women to their offspring. This research...
Common viruses trigger most cases of intussusception in children, suggests study Dr. Kamal Kant Kohli2 April 2024 7:30 PM ISTViral infections trigger more cases of intussusception, the common cause of bowel blockages in young children, than previously thought, according...
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants Ruchika Sharma31 March 2024 12:30 PM ISTCambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of...
Sanofi Gets CDSCO Panel Nod To Import, Market Nirsevimab to Treat Respiratory Syncytial Virus Disease Dr. Divya Colin27 March 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Sanofi Healthcare India has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Nirsevimab found Effective in Preventing RSV-Associated Hospitalizations Among Infants in new research Dr.Niharika Harsha B11 March 2024 12:45 AM ISTIn a significant development in pediatric healthcare, nirsevimab, a long-acting monoclonal antibody, has demonstrated robust real-world...
